and systemic tissue spread are also features of this stage. After the acute phase, patients enter an asymptomatic or indeterminate period, a long-lasting period of up to 10-30 We report the clinical course of five adult patients with chronic Chagas' disease (Cd) who underwent BMT.
4,5 immunofluorescent assay, ELISA and indirect hemagglutination tests were performed weekly from the start
Detection of high level of parasitemia has not been described during the course of chronic Cd in immunocomof chemotherapy until day +60 for ABMT and during the period of immunosuppression for allogeneic BMT.
petent individuals. However, in immunosuppressed patients reactivation of chronic Cd associated with leukemia, 6 lymNo prophylaxis was given to any of these patients. In only one ABMT patient were trypomastigotes detected phoma, 7 heart, 8 BM 9 and kidney transplantation 10 and HIV infection, 11 has been reported. early by blood culture without symptoms of reactivation. Benznidazole as preemptive treatment was We report the course of chronic Cd in five patients undergoing BMT and define control measures for early administered at 5-8 mg/kg/daily for 30 days. Parasitemia was rapidly cleared and at the end of therapy detection of parasitemia and/or reactivation using a preemptive approach to avoid the development of clinical disease. xenodiagnosis was negative. The other Cd patients showed no evidence of relapse of parasitemia or signs and symptoms of reactivation. In brief, evidence of Cd should be sought in all BMT patients coming from Materials and methods endemic areas because parasitemia and reactivation are potential complications during the period of neutroBetween January 1989 and December 1996 we performed 28 allogeneic and 206 ABMT. In allogeneic patients penia and immunosuppression. The strategy used for early detection and treatment of parasitemia and reactiimmunosuppressive therapy to prevent acute GVHD included CsA and MTX. Selection criteria for including vation was safe and effective. Keywords: Chagas' disease; bone marrow transplanpatients in this analysis were serologic reactivity against T. cruzi in recipients and/or donors before BMT. Patients were tation; benznidazole; immunosuppression; neutropenia followed up by parasitologic and serologic methods. Parasites in peripheral blood were detected by the Strout concentration method 12 which directly detects parasitemia Chagas' disease (Cd) is one of the major infectious probwithout enrichment media (patent parasitemia), and by lems in South America. The endemic area extends from the indirect blood culture 13 for three techniques to identify false positive and negative recovery was uneventful. Post-treatment control xenodiagnosis was also negative. Serological negativization and blood cultures for 2 months after ABMT and every 15 days up to the third month and monthly during the entire period discordance in titers of Ab anti-T. cruzi were observed when chronic and acute GVHD developed in two alloof pharmacological immunosuppression in allogeneic BMT. The requirements defining reactivation of chronic Cd geneic BMT patients, as shown in Table 2 . Two allogeneic and one ABMT patient died post transplant, all without after BMT were the detection of parasites in blood or cerebrospinal fluid when neurological signs were present and histopathological findings of Cd reactivation. Two ABMT patients (cases 1 and 5) survived up to the time of comby biopsies of cutaneous and deeply seated organ lesions when signs and symptoms of reactivation were present. pletion of this report (March 1997) without showing clinical manifestations of chronic Cd reactivation. Serological conversion was eventually considered in cases of transmission of infection. Preemptive therapy with benznidazole, a 2-nitroimidazole that blocks nucleic acid and protein synthesis was prescribed to those patients with Discussion parasitemia or tissue parasitism at a dose of 5-8 mg/kg/day for at least 30 days. Treatment was considered successful
We report the outcome of five adult patients with chronic Cd who underwent BMT. The low incidence of Cd patients when parasitemia was abrogated as determined by the Strout method during treatment and by xenodiagnosis (2%) could relate to the fact that our BMT unit is localized in a non-endemic area of Argentina. However, the paraafter therapy.
sitemia rate was high (20%), with one ABMT patient showing parasitemia without symptoms, detected early during the neutropenic period and successfully treated with benzniResults A 2% incidence rate of chronic Cd (five of 234 patients) Side-effects associated with benznidazole, mainly BM
